Mechanically Ventilated Patients
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
UNION therapeuticsDenmark - Hellerup
2 programs2
Remimazolam besylatePhase 21 trial
Remimazolam besylatePhase 21 trial
Active Trials
Humanwell PharmaceuticalMO - Ballwin
2 programsRemimazolam besylatePHASE_2
Remimazolam besylatePHASE_2
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
UNION therapeuticsRemimazolam besylate
UNION therapeuticsRemimazolam besylate
Clinical Trials (2)
Total enrollment: 72 patients across 2 trials
PK/PD Properties and Safety of Remazolam Besylate for Injection in ICU Patients With Impaired Renal Function
Start: Nov 2023Est. completion: Dec 202436 patients
Phase 2Unknown
Step 1 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients
Start: Apr 2022Est. completion: Feb 202336 patients
Phase 2Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.